Actively Recruiting

Age: 18Years +
All Genders
ID06513780

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Led by Ru-zhou Cai · Updated on 2025-09-18

700

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the connection between portal vein thrombosis (PVT) and outcomes after liver transplantation. The study aims to find out how common PVT is, what risk factors contribute to it, and how having PVT before surgery affects the prognosis of liver transplant patients. The goal also includes developing a new grading or rating system for PVT to improve clinical care. Participants are grouped into those with PVT and those without PVT before their liver transplant. The study does not involve any treatment or intervention but observes and compares data from both groups. Medical imaging, surgical details, pathology reports, treatments after surgery, and follow-up information will be collected and analyzed to understand PVT’s impact. During the study, researchers will gather demographic and laboratory data, imaging results, and clinical outcomes over time. The main outcomes measured include death, postoperative PVT, and portal vein narrowing over a 10-year period, along with complications within 1 year after surgery. The study monitors participants through their clinical records to build predictive models and clarify how PVT influences transplant prognosis.

CONDITIONS

Brief Title

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Liver transplantation recipients
  • Aged 18 years or older
Not Eligible

You will not qualify if you...

  • Retransplantation
  • Multi-organ transplantation
  • Portal vein tumor thrombus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 week

Participants undergo preoperative imaging such as ultrasound and/or computed tomography to determine the presence or absence of portal vein thrombosis before liver transplantation.

1 to 2 visits depending on imaging schedule

Monitoring

Duration - Up to 10 years

Participants who undergo routine liver transplantation are observed to collect data on perioperative medical imaging, surgical procedures, pathology reports, postoperative treatments, and clinical outcomes.

Follow-up visits according to clinical care over 10 years

Trial Site Locations

Total: 1 location

1

Beijing Friendship Hospital, Capital Medical University

Beijing, China

Actively Recruiting

Loading map...

Research Team

R

Ru-zhou Cai, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here